Beyond Air, Inc. (NASDAQ:XAIR)
| Market Cap | 1.85M-95.0% |
| Revenue (ttm) | n/a |
| Net Income | n/a |
| EPS | n/a |
| Shares Out | 984.41K |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 13,376 |
| Open | 2.76 |
| Previous Close | 2.54 |
| Day's Range | 2.49 - 2.76 |
| 52-Week Range | 2.38 - 55.60 |
| Beta | 0.15 |
| Analysts | Buy |
| Price Target | 10.00(+289.11%) |
| Earnings Date | n/a |
Beyond Air, Inc. has a live Insider Score.
Scored on 2 qualifying trades from 2 insiders in the last 90 days.
About XAIR
Beyond Air, Inc. functions as a specialized entity involved in both the development of medical devices and biopharmaceutical solutions. A central part of its operations is the LungFit platform, an innovative system that generates and delivers nitric oxide. Within this platform, LungFit PH is currently available, used to address persistent pulmonary hypertension in infants. Furthermore, the company is advancing LungFit PRO, a product intended for various viral lung ailments like community-acquired viral pneumonia (including COVID-19) and bronchiolitis in hospital settings. It is also creating LungFit GO, which aims to treat nontuberculous mycobacteria infections. The organization adopted its current name, Beyond Air, Inc., in June 2019, having previously been known as AIT Therapeutics, Inc. Its headquarters are situated in Garden City, New York.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$XAIR stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in XAIR holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by XAIR's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
XAIR Estimated quarterly lobbying spending
Source: U.S. Senate LDA
U.S. Patents
New XAIR patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to XAIR from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in XAIR
| ETF | Est. Holding Size |
|---|---|
| VXFVanguard Extended Market ETF | $12.46K |
Estimated from each fund’s disclosed top holdings × AUM
XAIR Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from XAIR’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score